May 15, 2025
Source: drugdu
73
May 13, Tonghua Dongbao, the company announced that it had recently received a drug registration certificate for protamine human insulin injection approved and issued by the National Health Regulatory Agency of Nicaragua (ANRS). Protamine human insulin injection is suitable for type 1 or type 2 diabetes. The main ingredient is human insulin, which is produced through genetic recombination technology. It can promote the uptake and utilization of glucose by tissues such as the liver, muscle and fat, inhibit the decomposition of liver glycogen and gluconeogenesis, and thus lower blood sugar levels. Protamine can slowly release insulin and prolong its duration of action.
https://finance.eastmoney.com/a/202505133403178852.html
By editoryour submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.